Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade.

An oral capsule combining finasteride and tadalafil was recently approved in the USA for signs and symptoms of benign prostatic hyperplasia (BPH). The authors argue that this new formulation has a limited role in the management of BPH and represents an avoidable prescribing cascade and low-value care.

Immune Cell Infiltration Predicts Response to Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer – Expert Commentary

Incorporating neoadjuvant chemotherapy (NAC) into the management of patients with localized muscle-invasive bladder cancer (MIBC) improves survival. However, due to multiple factors, NAC is still not effectively used in real-life settings. Moreover, there is are established predictor biomarkers to guide clinicians to choose the most beneficial treatment with the least possible toxicities.

EAU22 Postponed: New dates soon

We regret to inform you that we have been forced to postpone the 37th Annual EAU Congress in Amsterdam to late spring or early summer. The reason for this unfortunate decision is that the Dutch government’s rules and regulations currently do not permit the organisation of a meeting of our size. Although the Netherlands is […]

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial – Beyond the Abstract

Surgery and stereotactic ablative body radiotherapy (SABR) are commonly utilised in the setting of oligometastatic renal cell carcinoma (RCC) with the potential for durable remission in select patients. A majority will, however, progress at other sites and ultimately require systemic therapy. Single-agent immune checkpoint inhibitor (ICI) therapy had shown promising activity in the second line […]

Imaging Prostate Cancer: Clinical Utility of Prostate-specific Membrane Antigen (PSMA).

To review the pathway and pertinent materials leading to approval of PSMA scanning (prostate-specific membrane antigen) by the U.S. FDA. Beginning with the pivotal trials and working backward, we summarize the evolution of PSMA scanning, beginning with the discovery of the molecule, the mechanism of action to identify prostate cancer, the route to the present-day […]

Social constraints and cancer-related quality of life in single and partnered young adult testicular cancer survivors: a contextual approach.

To examine the context of relationship status on the link between friends/family social constraints (SCff) and cancer-related quality-of-life (QOL) among young adult testicular cancer survivors. Participants completed the Functional Assessment of Cancer Therapy (general version), the Social Constraints Scale (friends/family), and demographic questions.

X